James Edgemond United Therapeutics Corp (UTHR) insider trading activity

James Edgemond is CFO AND TREASURER of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 8,118 shares of UTHR, which is worth approximately $2.45 Million. The most recent transaction as insider was on Aug 26, 2024, when has been sold 8,332 shares (Common Stock) at a price of $119.01 per share, resulting in proceeds of $991,591. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.12K

0.62% 3M change

414.45% 12M change

Total Value Held $2.45 Million

JAMES EDGEMOND Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 26 2024	BUY Exercise of conversion of derivative security	$991,591 $119.01 p/Share	8,332 Added 72.31%	3,191 Common Stock
Aug 19 2024	SELL Open market or private sale	$2,575,568 $329.02 p/Share	7,828 Reduced 78.99%	2,082 Common Stock
Aug 19 2024	BUY Exercise of conversion of derivative security	$991,591 $119.01 p/Share	8,332 Added 75.71%	2,673 Common Stock
May 15 2024	SELL Open market or private sale	$10,951,230 $272.69 p/Share	40,160 Reduced 96.22%	1,578 Common Stock
May 15 2024	BUY Exercise of conversion of derivative security	$6,558,128 $163.3 p/Share	40,160 Added 70.58%	16,738 Common Stock
Nov 07 2022	SELL Sale (or disposition) back to the issuer	$1,977,254 $266.8 p/Share	7,411 Reduced 84.26%	1,384 Common Stock
Nov 07 2022	BUY Exercise of conversion of derivative security	$545,004 $73.54 p/Share	7,411 Added 66.13%	3,795 Common Stock

James Edgemond

CFO AND TREASURER

Silver Spring, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Value

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

Operation

Value

Type

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR

Account